Jill Strasser
Nurse Practitioner · Bridgeport, WVNPI 1083959803
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 351 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 23 manufacturers, the largest accounting for just 21.6% — the pattern of someone who eats at a lot of different presentations. Among nurse practitioner clinicians in WV with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 351 payments — averaging $16.01 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$669
- Otsuka America Pharmaceutical, Inc.$527
- Alkermes, Inc.$495
- Axsome Therapeutics, Inc.$491
- Takeda Pharmaceuticals U.S.A., Inc.$411
- plus $2K from 17 others
What the payments were for
- Food & beverage$5,621100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 93 | $1,214 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 65 | $669 |
| Otsuka America Pharmaceutical, Inc. | 29 | $527 |
| Alkermes, Inc. | 25 | $495 |
| Axsome Therapeutics, Inc. | 24 | $491 |
| Takeda Pharmaceuticals U.S.A., Inc. | 29 | $411 |
| Corium, LLC | 10 | $284 |
| Johnson & Johnson | 10 | $271 |
| Teva Pharmaceuticals USA, Inc. | 15 | $263 |
| Neurocrine Biosciences, Inc. | 9 | $182 |
| Indivior Inc. | 10 | $178 |
| Tris Pharma Inc | 7 | $138 |
| Lundbeck LLC | 7 | $132 |
| Ironshore Pharmaceuticals Inc. | 5 | $104 |
| Vanda Pharmaceuticals Inc. | 3 | $53 |
| E.r. Squibb & Sons, L.L.C. | 2 | $53 |
| Braeburn Inc. | 2 | $40 |
| Sunovion Pharmaceuticals Inc. | 1 | $29 |
| Sage Therapeutics, LLC | 1 | $25 |
| Neos Therapeutics, LP | 1 | $16 |
| Neuronetics, Inc. | 1 | $16 |
| Almatica Pharma LLC | 1 | $15 |
| Supernus Pharmaceuticals, Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$5,621 in reported general payments places this provider in the 95th percentile of 649 nurse practitioner providers in West Virginia.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| IngrezzaValbenazine Tosylate | 11 | $85,066 |
| CaplytaLumateperone Tosylate | 12 | $27,778 |
| SpravatoEsketamine Hcl | 13 | $16,523 |
| TrintellixVortioxetine Hydrobromide | 17 | $16,500 |
| VyvanseLisdexamfetamine Dimesylate | 21 | $7,801 |
| Lisdexamfetamine Dimesylate | 11 | $2,811 |
| Quetiapine Fumarate ErQuetiapine Fumarate | 16 | $1,739 |
| Fluoxetine Hcl | 52 | $1,676 |
| Desvenlafaxine Succinate ErDesvenlafaxine Succinate | 19 | $1,430 |
| Duloxetine Hcl | 42 | $843 |
| Lorazepam | 72 | $662 |
| Olanzapine | 12 | $550 |
| Quetiapine Fumarate | 31 | $403 |
| Bupropion XlBupropion Hcl | 26 | $363 |
| Lamotrigine | 39 | $354 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Neurocrine Biosciences, Inc.Ingrezza | $182 | $85,06611 claims |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)Caplyta | $669 | $27,77812 claims |
| Takeda Pharmaceuticals U.S.A., Inc.Trintellix, Vyvanse | $411 | $24,30138 claims |
| Johnson & JohnsonSpravato | $271 | $16,52313 claims |
| Almatica Pharma LLCSertraline Hcl | $15 | $23822 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 649 nurse practitioner providers in West Virginia.
Other nurse practitioner in Bridgeport
- Vanessa HayesBridgeport$5K
- Daisy Culverhouse-PerryBridgeport$3K
- Meranda ChippsBridgeport$2K
- Leigh BrooksPrinceton$75K
- Destiny HowardBeckley$35K
- Rachael RigginsBeckley$19K
- Lacy HowardWheeling$18K
- Robin BlumeBeckley$18K
- Kellie VaughtBeckley$17K
- Lisa WalkerBeckley$17K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.